Community pharmacists can spot early signs of cancer, research shows
A lack of awareness about pharmacist’s professional skills and a disregard for their own symptoms lead to delays in cancer patients seeking medical help.
Community pharmacists have the potential to help identify early signs of cancer in patients and refer them to specialists, according to .
However, engagement is hampered by a lack of public awareness of pharmacist’s professional skills, the study results show.
“Despite recent awareness campaigns people still fail to recognise their cancer symptoms, they self-medicate and delay seeking help,” the University of Aberdeen researchers wrote.
“In this study, many of the participants attended community pharmacies to purchase medicines but did not interact with the pharmacist about their symptoms. Those who did interact with the pharmacist were referred and were subsequently diagnosed with cancer, confirming appropriateness.”
The authors added that there is “potential for more community pharmacist involvement in both advising on symptoms and referring on”.
“However, for this to happen patients need to make more use of pharmacists’ skills.” More research was needed before any interventions could be designed, they said.
The researchers based their conclusions on the results of face-to-face interviews, interpreted using a qualitative data analysis framework, with 25 patients who attended outpatient clinics at Aberdeen Royal Infirmary. All had been diagnosed in the previous 12 months with lung, colorectal, or gastro-oesophageal cancer. The interviews took up to 60 minutes.
They found that patients were widely unaware of risk factors and red-flag symptoms associated with cancer. Some participants did not attribute their symptoms to anything until they were diagnosed; the majority never thought they had cancer.
A few patients chose to visit a pharmacy before seeking help from their GP. While most did not speak to counter staff or the pharmacist, the three patients who did seek pharmacist advice were appropriately referred and were happy with the advice and treatment given.
“The main barrier to accessing pharmacy support was a lack of awareness that pharmacists were suitably skilled to respond appropriately to their symptoms,” the researchers concluded.
Citation: Jizak DOI: 10.1211/PJ.2018.20205518
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00
Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.£35.00
Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.£38.00
The 2016 pocket guide to drug interactions and their management, for the busy healthcare professional.£31.00